AbbVie
ABBV
#25
Rank
โ‚น46.912 T
Marketcap
โ‚น26,540
Share price
1.01%
Change (1 day)
28.78%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): โ‚น1.205 Trillion

According to AbbVie's latest financial reports the company's current earnings are โ‚น66.01 Billion. In 2025 the company made an earning of โ‚น611.34 Billion, an increase over its 2024 earnings that were of โ‚น344.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น1.205 T97.26%
2025 โ‚น611.34 B77.53%
2024 โ‚น344.36 B-40.54%
2023 โ‚น579.18 B-53.62%
2022 โ‚น1.248 T3.76%
2021 โ‚น1.203 T282.25%
2020 โ‚น314.89 B-59.67%
2019 โ‚น780.83 B62.13%
2018 โ‚น481.60 B-32.74%
2017 โ‚น716.06 B-1.99%
2016 โ‚น730.61 B18.65%
2015 โ‚น615.79 B180.5%
2014 โ‚น219.53 B-55.57%
2013 โ‚น494.11 B-6.86%
2012 โ‚น530.52 B56.05%
2011 โ‚น339.96 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น645.72 B-45.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.222 T 171.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1.024 T-13.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น41.24 B-96.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น234.74 Billion-119.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.050 T-11.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.398 T 17.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น663.00 B-44.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น79.97 B-93.27%๐Ÿ‡บ๐Ÿ‡ธ USA